Late-stage biotech developing therapies for acute migraines.
Industry: Health Care
First Day Return: -20.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/30/2015 |
Offer Price | $10.00 |
Price Range $10.00 - $10.00 | |
Offer Shares (mm) | 5.5 |
Deal Size ($mm) | $55 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/05/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $55 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Burlington, MA, United States |
Founded | 2005 |
Employees at IPO | 5 |
Website www.colucid.com |